Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-17

Clinical Trial Update: Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903) [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing terlipressin to octreotide using functional MRI to assess renal function in cirrhotic patients with acute variceal bleeding.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OCTREOTIDE (OCTREOTIDE ACETATE)
  • Terlipressin (terlipressin)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Renal Function Disorder, Acute Variceal Bleeding | Phase 4 | Status: UNKNOWN